Crystal structure of Enterovirus A71 2A protease mutant C110A containing VP1-2A junction in the active site apo structure (C1 PDB: 9FGO) used for fragment screen and compound soaking v1
This protocol describes the crystallization of Enterovirus 71 (EV-71) 2A protease mutant C110A containing the VP1-2A junction in the active site. The crystals form within 12-24 hours using a crystallization screen composed of 1.8M NaCl and 15% ethanol. The crystal structure was determined using X-ray diffraction, resulting in hexagonal prism crystals in space group P61 with unit cell dimensions of 61.5Å, 61.5Å, 78.9Å (90.00°, 90.00°, 120.00°) and an average resolution of 1.5Å. The protein was expressed using the plasmid Enterovirus Coxsackievirus A71 2A protease 228633.
Authors
- Xiaomin Ni (ORCID: https://orcid.org/0000-0002-7769-8297)
- L. Koekemoer (ORCID: https://orcid.org/0000-0001-9226-9127)
- D. Fearon (ORCID: https://orcid.org/0000-0003-3529-7863)
- Peter Marples (ORCID: https://orcid.org/0000-0002-8787-7969)
Institutions
- Diamond Light Source (GB)
Publication Details
- Published
- 2025-03-04
- DOI
- https://doi.org/10.17504/protocols.io.6qpvr9b52vmk/v1
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Diamond Light Source
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases